Castration Resistant Prostate Adenocarcinoma
1 clinical trials · Condition
◉ Watch Castration Resistant Prostate Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies (NCT03365791) | Novartis Pharmaceuticals | 2018-01-24 |
Track Castration Resistant Prostate Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.